Adhera Therapeutics Financials
| ATRX Stock | USD 0.0001 0.00 0.00% |
Adhera |
Understanding current and past Adhera Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Adhera Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Adhera Therapeutics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Adhera Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Adhera Therapeutics. Check Adhera Therapeutics' Beneish M Score to see the likelihood of Adhera Therapeutics' management manipulating its earnings.
Adhera Therapeutics Stock Summary
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. Adhera Therapeutics is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US00687E1091 |
| Business Address | 8000 Innovation Parkway, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | adherathera.com |
| Phone | 919 518 3748 |
| Currency | USD - US Dollar |
Adhera Therapeutics Key Financial Ratios
Adhera Therapeutics' financial ratios allow both analysts and investors to convert raw data from Adhera Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Adhera Therapeutics over time and compare it to other companies across industries.Adhera Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Adhera Therapeutics's current stock value. Our valuation model uses many indicators to compare Adhera Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adhera Therapeutics competition to find correlations between indicators driving Adhera Therapeutics's intrinsic value. More Info.Adhera Therapeutics is rated below average in return on asset category among its peers. It is rated third in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Adhera Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Adhera Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Adhera Therapeutics Systematic Risk
Adhera Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Adhera Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Adhera Therapeutics correlated with the market. If Beta is less than 0 Adhera Therapeutics generally moves in the opposite direction as compared to the market. If Adhera Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Adhera Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Adhera Therapeutics is generally in the same direction as the market. If Beta > 1 Adhera Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Adhera Therapeutics October 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Adhera Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Adhera Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Adhera Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Adhera Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Adhera Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1218 | |||
| Maximum Drawdown | 9999.0 |
Additional Tools for Adhera Pink Sheet Analysis
When running Adhera Therapeutics' price analysis, check to measure Adhera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adhera Therapeutics is operating at the current time. Most of Adhera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Adhera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adhera Therapeutics' price. Additionally, you may evaluate how the addition of Adhera Therapeutics to your portfolios can decrease your overall portfolio volatility.